Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: A single-center analysis

Annals of Hematology

Volumn 93, Issue 8, 2014, Pages 1287-1295

  Wöhrer, Stefan ^a   Kiesewetter, Barbara ^a   Fischbach, Julia ^a   Müllauer, Leonhard ^a   Troch, Marlene ^a   Lukas, Julius ^a   Mayerhoefer, Marius E ^a   Raderer, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antibacterial agents; Drug therapy; MALT lymphoma; Radiotherapy; Surgery

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 MICROGLOBULIN; LACTATE DEHYDROGENASE;

ADULT; AGED; ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; MONOCLONAL IMMUNOGLOBULINEMIA; PATIENT CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REMISSION; THYROID GLAND;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; AUSTRIA; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EYE NEOPLASMS; HUMANS; IMMUNOTHERAPY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHOMA, B-CELL, MARGINAL ZONE; MIDDLE AGED; ORGAN SPECIFICITY; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 84904728743     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2042-z     Document Type: Article

References (33)

1. Harris NL, Jaffe ES, Diebold J et al (2000) The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol 13:193-207 (Pubitemid 30109108)
2. Novak U, Basso K, Pasqualucci L et al (2011) Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells. Br J Haematol 155:362-365
3. Hussell T, Isaacson PG, Crabtree JE et al (1993) The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342:571-574 (Pubitemid 23259232)
4. Zucca E, Conconi A, Pedrinis E et al (2003) Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101:2489-2495 (Pubitemid 36857603)
5. Ambrosetti A, Zanotti R, Pattaro C et al (2004)Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol 126:43-49 (Pubitemid 38859480)
6. Ramos-Casals M, la Civita L, de Vita S et al (2007) Characterization of B cell lymphoma in patients with Sjogren's syndrome and hepatitis C virus infection. Arthritis Rheum 57:161-170
7. Libra M, Gloghini A, Malaponte G et al (2008) Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas. J Hepatol 49:170-174
8. Wotherspoon AC, Doglioni C, Diss TC et al (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577 (Pubitemid 23259233)
9. Pinotti G, Zucca E, Roggero E et al (1997) Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 26:527-537 (Pubitemid 27477778)
10. Ruskone-Fourmestraux A, Fischbach W, Aleman BM et al (2011) EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 60:747-758
11. Zucca E, Dreyling M (2010) Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Suppl 5:v175-v176
12. Raderer M, Wohrer S, Streubel B et al (2006) Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 24:3136-3141 (Pubitemid 46646224)
13. de Boer JP, Hiddink RF, Raderer M et al (2008)Dissemination patterns in non-gastric MALT lymphoma. Haematologica 93:201-206 (Pubitemid 351397708)
14. Goda JS, Gospodarowicz M, Pintilie M et al (2010) Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 116:3815-3824
15. Kiesewetter B, Troch M, Dolak Wet al (2013) A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma). Haematologica 98:353-356
16. Troch M, Kiesewetter B, Raderer M (2011) Recent developments in nongastric mucosa-associated lymphoid tissue lymphoma. Curr Hematol Malig Rep 6:216-221
17. Troch M, Jonak C, Mullauer L et al (2009) A phase II study of bortezomib in patients with MALT lymphoma. Haematologica 94:738-742
18. Raderer M, Wohrer S, Streubel B et al (2006) Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma. Oncology 70:411-417 (Pubitemid 46335680)
19. Troch M, Kiesewetter B, Willenbacher W et al (2013) Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie. Haematologica 98:264-268
20. Salar A, Domingo-Domenech E, Estany C et al (2009) Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Cancer 115:5210-5217
21. Grunberger B, Wohrer S, Streubel B et al (2006) Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol 24:1370-1375 (Pubitemid 46622000)
22. Wohrer S, Drach J, Hejna M et al (2003) Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol 14:1758-1761 (Pubitemid 38029047)
23. Jager G, Neumeister P, Brezinschek R et al (2002) Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 20:3872-3877
24. Aviles A, Nambo MJ, Neri N et al (2005) Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial. Med Oncol 22:57-62 (Pubitemid 40647230)
25. Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579-586 (Pubitemid 350002966)
26. Carbone PP, Kaplan HS, Musshoff K et al (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861
27. Fischbach W, Goebeler-Kolve ME, Dragosics B et al (2004) Long termoutcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 53:34-37 (Pubitemid 38083007)
28. Solal-Celigny P, Roy P, Colombat P et al (2004) Follicular lymphoma international prognostic index. Blood 104:1258-1265 (Pubitemid 39166497)
29. (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994
30. Greipp PR, San Miguel J, Durie BG et al (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412-3420
31. Wohrer S, Troch M, Streubel B, et al (2007) Pathology and clinical course of MALT lymphoma with plasmacytic differentiation. Ann Oncol 18:2020-2024 (Pubitemid 350286243)
32. Wohrer S, Streubel B, Bartsch R et al (2004) Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res 10:7179-7181 (Pubitemid 39487703)
33. Wohrer S, Troch M, Streubel B et al (2007) MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course. Leukemia 21:1812-1818 (Pubitemid 47086770)